Notification about latest news from us.
Trump's tariffs pose significant challenges for the pharmaceutical industry, impacting costs and accessibility.
Major drug companies plan to raise prices on over 250 medications in the U.S., effective January 1, 2025, with median increases around 4.5%.
Trump's proposed tariffs may raise drug prices and cause shortages, impacting the U.S. pharmaceutical market by increasing the cost and availability of medications.
By clicking send you'll receive occasional emails from newsletters about this topic.